Clinical Trial: A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07814352) titled 'A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease' on Sept. 04.

Brief Summary: The researchers are doing this study to find out whether SX-682 in combination with proton craniospinal irradiation (pCSI) is a safe treatment approach for people with melanoma or non-small cell lung cancer (NSCLC) with leptomeningeal disease (LMD). The researchers will also look at whether the treatment combination is effective against participants' cancer.

Study Start Date: Sept. 04

Study Type: INTERVENTIONAL

Condition: Leptomeningeal Disease (LMD)

Intervention: DRUG: SX-682

Patien...